Johnson & Johnson has brought its bladder cancer drug TAR-200 to the US market, a year after its prospects were dented by a negative phase 3 readout. The novel formulation of the stalwart ...
"Institutionalist Democrats have held the party hostage, offering only controlled opposition to a far-right that infringes on more constitutional liberties by the day. This is about the inability of a ...